Shopping Cart 0
Cart Subtotal
AED 0

Urology Devices Market: Current Analysis and Forecast (2021-2027)

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Single User License
AED 14676

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Site License
AED 18713

Details

Prevalence of various urological disorders has led to an upsurge in adoption of the urology devices globally. For instance, according to the American Urological Association Foundation (AUAF), benign prostatic hyperplasia (BPH), urinary incontinence (UI), urinary tract infections (UTIS), and kidney and ureteral stones are among the most common urological diseases. Moreover, as per the United States Department of Health and Human Services, the overall prevalence of CKD among the American population is about 14%, and almost half of the individuals with CKD suffer from diabetes and/or cardiovascular diseases. Annually, more than 661,000 Americans suffer from kidney failure, and 468,000 patients are given dialysis.

Urinary tract infections (UTIs) are one of the most common microbial diseases affecting people of all age groups. Globally, UTIs affect around 150 million people every year. Diabetic patients have a higher risk of developing UTIs and complications associated with it. With a global increase in diabetic population, complications, like dysuria and organ damage are associated with UTIs, that are also on the rise.

Based on product, the global Urology Devices market is segmented into instruments and consumables & accessories. Currently, instruments segment dominated the market and is expected to maintain its dominance during the forecast period owing to the technological advancements coupled with the launch of new and advanced urology instruments.

Based on diseases, the market is divided into kidney diseases, urological cancer and BPH, pelvic organ prolapse, and other diseases. Kidney diseases dominated the market in 2020 owing to the growing patient pool of chronic kidney disease due to the rising geriatric population.

Based on end-users, the market is segmented into hospitals and clinics, dialysis centers and others. Currently hospitals dominates the market and is expected to maintain its dominance during the analyzed period owing to the rising number of hospitals and infrastructural & economic development, especially in emerging countries.

For a better understanding of the market adoption, report provide detailed analysis for major region and countries including North America (US, Canada, Rest of North America), Europe (Germany, France, Spain, United Kingdom, Italy, Rest of Europe), Asia-Pacific (China, Japan, India, Australia, and Rest of APAC), and Rest of World. North America constitutes a major market for Urology Devices on account of increasing prevalence of chronic and lifestyle conditions, increasing healthcare spending, highly developed healthcare system in the US and Canada, and presence of a better reimbursement structure.

Some of the major players operating in the market includes Baxter, Boston Scientific, C. R. Bard, Medtronic, Siemens, Fresenius Medical Care AG & Co. KGaA, B. Braun Melsungen AG, Becton, Dickinson and Company, Stryker Corporation, and Sanofi; etc.

READ MORE

Table Of Content

Scope

1 MARKET INTRODUCTION

1.1 Market Definitions

1.2 Objective of the Study

1.3 Limitation

1.4 Stake Holders

1.5 Currency Used in Report

1.6 Scope of the Global Urology Devices Market Study

2 RESEARCH METHODOLOGY OR ASSUMPTION

2.1 Research Methodology for the Global Urology Devices Market

2.1.1 Main Objective of the Global Urology Devices Market

3 MARKET SYNOPSIS

4 EXECUTIVE SUMMARY

5 TOP START-UPs UNDER UROLOGY DEVICES INDUSTRY

6 COVID-19 IMPACT

7 GLOBAL UROLOGY DEVICES MARKET REVENUE

8 MARKET INSIGHTS BY PRODUCT

8.1 Instruments

8.1.1 Dialysis Devices

8.1.2 Endoscopes and Endovision Systems

8.1.3 Lasers and Lithotripsy Devices

8.1.4 Other Instruments

8.2 Consumables and Accessories

8.2.1 Dialysis Consumables

8.2.2 Guidewires and Catheters

8.2.3 Stents

8.2.4 Biopsy Devices

8.2.5 Other Consumables and Accessories

9 MARKET INSIGHTS BY DISEASES

9.1 Kidney Diseases

9.2 Urological Cancer and BPH

9.3 Pelvic Organ Prolapse

9.4 Other Diseases

10 MARKET INSIGHTS BY END-USERS

10.1 Hospitals and Clinics

10.2 Dialysis Centers

10.3 Other End Users

11 MARKET INSIGHTS BY REGION

11.1 NORTH AMERICA UROLOGY DEVICES MARKET

11.1.1 United States

11.1.2 Canada

11.1.3 Rest of North America

11.2 EUROPE UROLOGY DEVICES MARKET

11.2.1 Germany

11.2.2 France

11.2.3 United Kingdom

11.2.4 Spain

11.2.5 Italy

11.2.6 Rest of Europe

11.3 ASIA PACIFIC UROLOGY DEVICES MARKET

11.3.1 China

11.3.2 Japan

11.3.3 India

11.3.4 Australia

11.3.5 Rest of Asia Pacific

11.4 REST OF THE WORLD UROLOGY DEVICES MARKET

12 UROLOGY DEVICES MARKET DYNAMICS

12.1 Market Drivers

12.2 Market Challenges

12.3 Impact Analysis

13 LEGAL & REGULATORY FRAMEWORK

14 DEMAND AND SUPPLY SIDE ANALYSIS

14.1 Demand Side Analysis

14.2 Supply Side Analysis

14.2.1 Top Product Launches

14.2.2 Top Business Partnerships

14.2.3 Top Merger & Acquisitions

15 VALUE CHAIN ANALYSIS

16 UROLOGY DEVICES MARKET OPPORTUNITIES

17 UROLOGY DEVICES MARKET TRENDS & INSIGHTS

18 COMPETITIVE SCENARIO

18.1 Porter's Five forces analysis

18.1.1 Bargaining power of Supplier

18.1.2 Bargaining power of Buyer

18.1.3 Industry Rivalry

18.1.4 Availability of Substitute

18.1.5 Threat of new Entrants

18.2 Competitive Landscape

19.2.1 Company Shares, By Revenue

19 COMPANY PROFILED

19.1 Medtronic plc

19.1.1 Key Facts

19.1.2 Business Description

19.1.3 Key Product/Services Offerings Revenue Split

19.1.4 Growth Strategy Financial Overview of Medtronic plc

19.1.5 SWOT Analysis

19.1.6 Key Financials Product Launch

19.1.6.1 Partnerships

19.1.6.2 Business Expansion and Investments

19.1.7 Recent Developments Merger and Acquisition

19.1.7.1 Product Launch

19.1.7.2 Partnerships

19.1.7.3 Business Expansion and Investments

19.1.7.4 Merger and Acquisition

19.2 Boston Scientific

19.3 C. R. Bard

19.4 Baxter

19.5 Siemens

19.6 Fresenius Medical Care AG & Co. KGaA

19.7 B. Braun Melsungen AG

19.8 Becton, Dickinson and Company

19.9 Stryker Corporation

19.10 Sanofi

20 DISCLAIMER

Licence Rights

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies


Companies

Baxter

Boston Scientific

C. R. Bard

Medtronic

Siemens

Fresenius Medical Care AG & Co. KGaA

B. Braun Melsungen AG

Becton

Dickinson and Company

Stryker Corporation

and Sanofi

Company Profile

Company Profile Title

Prevalence of various urological disorders has led to an upsurge in adoption of the urology devices globally. For instance, according to the American Urological Association Foundation (AUAF), benign prostatic hyperplasia (BPH), urinary incontinence (UI), urinary tract infections (UTIS), and kidney and ureteral stones are among the most common urological diseases. Moreover, as per the United States Department of Health and Human Services, the overall prevalence of CKD among the American population is about 14%, and almost half of the individuals with CKD suffer from diabetes and/or cardiovascular diseases. Annually, more than 661,000 Americans suffer from kidney failure, and 468,000 patients are given dialysis.

Urinary tract infections (UTIs) are one of the most common microbial diseases affecting people of all age groups. Globally, UTIs affect around 150 million people every year. Diabetic patients have a higher risk of developing UTIs and complications associated with it. With a global increase in diabetic population, complications, like dysuria and organ damage are associated with UTIs, that are also on the rise.

Based on product, the global Urology Devices market is segmented into instruments and consumables & accessories. Currently, instruments segment dominated the market and is expected to maintain its dominance during the forecast period owing to the technological advancements coupled with the launch of new and advanced urology instruments.

Based on diseases, the market is divided into kidney diseases, urological cancer and BPH, pelvic organ prolapse, and other diseases. Kidney diseases dominated the market in 2020 owing to the growing patient pool of chronic kidney disease due to the rising geriatric population.

Based on end-users, the market is segmented into hospitals and clinics, dialysis centers and others. Currently hospitals dominates the market and is expected to maintain its dominance during the analyzed period owing to the rising number of hospitals and infrastructural & economic development, especially in emerging countries.

For a better understanding of the market adoption, report provide detailed analysis for major region and countries including North America (US, Canada, Rest of North America), Europe (Germany, France, Spain, United Kingdom, Italy, Rest of Europe), Asia-Pacific (China, Japan, India, Australia, and Rest of APAC), and Rest of World. North America constitutes a major market for Urology Devices on account of increasing prevalence of chronic and lifestyle conditions, increasing healthcare spending, highly developed healthcare system in the US and Canada, and presence of a better reimbursement structure.

Some of the major players operating in the market includes Baxter, Boston Scientific, C. R. Bard, Medtronic, Siemens, Fresenius Medical Care AG & Co. KGaA, B. Braun Melsungen AG, Becton, Dickinson and Company, Stryker Corporation, and Sanofi; etc.

READ MORE

Scope

1 MARKET INTRODUCTION

1.1 Market Definitions

1.2 Objective of the Study

1.3 Limitation

1.4 Stake Holders

1.5 Currency Used in Report

1.6 Scope of the Global Urology Devices Market Study

2 RESEARCH METHODOLOGY OR ASSUMPTION

2.1 Research Methodology for the Global Urology Devices Market

2.1.1 Main Objective of the Global Urology Devices Market

3 MARKET SYNOPSIS

4 EXECUTIVE SUMMARY

5 TOP START-UPs UNDER UROLOGY DEVICES INDUSTRY

6 COVID-19 IMPACT

7 GLOBAL UROLOGY DEVICES MARKET REVENUE

8 MARKET INSIGHTS BY PRODUCT

8.1 Instruments

8.1.1 Dialysis Devices

8.1.2 Endoscopes and Endovision Systems

8.1.3 Lasers and Lithotripsy Devices

8.1.4 Other Instruments

8.2 Consumables and Accessories

8.2.1 Dialysis Consumables

8.2.2 Guidewires and Catheters

8.2.3 Stents

8.2.4 Biopsy Devices

8.2.5 Other Consumables and Accessories

9 MARKET INSIGHTS BY DISEASES

9.1 Kidney Diseases

9.2 Urological Cancer and BPH

9.3 Pelvic Organ Prolapse

9.4 Other Diseases

10 MARKET INSIGHTS BY END-USERS

10.1 Hospitals and Clinics

10.2 Dialysis Centers

10.3 Other End Users

11 MARKET INSIGHTS BY REGION

11.1 NORTH AMERICA UROLOGY DEVICES MARKET

11.1.1 United States

11.1.2 Canada

11.1.3 Rest of North America

11.2 EUROPE UROLOGY DEVICES MARKET

11.2.1 Germany

11.2.2 France

11.2.3 United Kingdom

11.2.4 Spain

11.2.5 Italy

11.2.6 Rest of Europe

11.3 ASIA PACIFIC UROLOGY DEVICES MARKET

11.3.1 China

11.3.2 Japan

11.3.3 India

11.3.4 Australia

11.3.5 Rest of Asia Pacific

11.4 REST OF THE WORLD UROLOGY DEVICES MARKET

12 UROLOGY DEVICES MARKET DYNAMICS

12.1 Market Drivers

12.2 Market Challenges

12.3 Impact Analysis

13 LEGAL & REGULATORY FRAMEWORK

14 DEMAND AND SUPPLY SIDE ANALYSIS

14.1 Demand Side Analysis

14.2 Supply Side Analysis

14.2.1 Top Product Launches

14.2.2 Top Business Partnerships

14.2.3 Top Merger & Acquisitions

15 VALUE CHAIN ANALYSIS

16 UROLOGY DEVICES MARKET OPPORTUNITIES

17 UROLOGY DEVICES MARKET TRENDS & INSIGHTS

18 COMPETITIVE SCENARIO

18.1 Porter's Five forces analysis

18.1.1 Bargaining power of Supplier

18.1.2 Bargaining power of Buyer

18.1.3 Industry Rivalry

18.1.4 Availability of Substitute

18.1.5 Threat of new Entrants

18.2 Competitive Landscape

19.2.1 Company Shares, By Revenue

19 COMPANY PROFILED

19.1 Medtronic plc

19.1.1 Key Facts

19.1.2 Business Description

19.1.3 Key Product/Services Offerings Revenue Split

19.1.4 Growth Strategy Financial Overview of Medtronic plc

19.1.5 SWOT Analysis

19.1.6 Key Financials Product Launch

19.1.6.1 Partnerships

19.1.6.2 Business Expansion and Investments

19.1.7 Recent Developments Merger and Acquisition

19.1.7.1 Product Launch

19.1.7.2 Partnerships

19.1.7.3 Business Expansion and Investments

19.1.7.4 Merger and Acquisition

19.2 Boston Scientific

19.3 C. R. Bard

19.4 Baxter

19.5 Siemens

19.6 Fresenius Medical Care AG & Co. KGaA

19.7 B. Braun Melsungen AG

19.8 Becton, Dickinson and Company

19.9 Stryker Corporation

19.10 Sanofi

20 DISCLAIMER

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS


Companies

Baxter

Boston Scientific

C. R. Bard

Medtronic

Siemens

Fresenius Medical Care AG & Co. KGaA

B. Braun Melsungen AG

Becton

Dickinson and Company

Stryker Corporation

and Sanofi